In this issue:
Upadacitinib for adolescents with moderate–severe AD
Infection risk in rituximab-treated pemphigus
IVIG for bullous pemphigoid after insufficient response to corticosteroids
PNI and RAR for predicting severity and mortality in SJS-TEN
Sleep outcomes with crisaborole in paediatric AD
5-fluorouracil ± emollient for AK
Secukinumab for severe biologic-refractory hidradenitis suppurativa
0.025% vs. 0.05% tretinoin cream for acanthosis nigricans
Events of special interest with baricitinib in at-risk populations
Ablative fractional laser-assisted PDT for AK
Please login below to download this issue (PDF)